This is one of many articles that have been in the media about a new blood test that will improve how we assess and treat traumatic brain injuries. The test, which is the first of its kind to be approved by the FDA, should almost completely replace the CT scan as a way to rule out bleeding in the brain. It measures levels of two proteins, named GFAP and UCH-L1, which spill out of neurons when they are injured. It is a very reliable test, meaning that it will be used for many of the 2.8 million Americans who present to emergency departments after a head injury every year.

This will prevent unnecessary radiation exposure, which is linked to a small but significant increased risk of cancer. While it doesn’t directly improve outcomes for people who struggle after concussion injuries, there may be an indirect benefit. This is because radiation may also impact recovery in vulnerable brains. While this link has not been well studied, it makes sense.

At Seekers, our approach includes healing the nervous system, and this certainly includes the brain. Take care of yours.

Read the full article here